report cover

Global Evolocumab Market Research Report 2022

  • 04 November 2022
  • Life Sciences
  • 117 Pages
  • Report code : 24WT-7474337

Evolocumab Market

1 Evolocumab Market Overview
1.1 Product Overview and Scope of Evolocumab
1.2 Evolocumab Segment by Type
1.2.1 Global Evolocumab Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Patent
1.2.3 Generic
1.3 Evolocumab Segment by Application
1.3.1 Global Evolocumab Sales Comparison by Application: (2022-2028)
1.3.2 Chemical
1.3.3 Pharmaceutical
1.4 Global Evolocumab Market Size Estimates and Forecasts
1.4.1 Global Evolocumab Revenue 2017-2028
1.4.2 Global Evolocumab Sales 2017-2028
1.4.3 Evolocumab Market Size by Region: 2017 Versus 2021 Versus 2028
2 Evolocumab Market Competition by Manufacturers
2.1 Global Evolocumab Sales Market Share by Manufacturers (2017-2022)
2.2 Global Evolocumab Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Evolocumab Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Evolocumab Manufacturing Sites, Area Served, Product Type
2.5 Evolocumab Market Competitive Situation and Trends
2.5.1 Evolocumab Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Evolocumab Players Market Share by Revenue
2.5.3 Global Evolocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Evolocumab Retrospective Market Scenario by Region
3.1 Global Evolocumab Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Evolocumab Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Evolocumab Market Facts & Figures by Country
3.3.1 North America Evolocumab Sales by Country
3.3.2 North America Evolocumab Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Evolocumab Market Facts & Figures by Country
3.4.1 Europe Evolocumab Sales by Country
3.4.2 Europe Evolocumab Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Evolocumab Market Facts & Figures by Region
3.5.1 Asia Pacific Evolocumab Sales by Region
3.5.2 Asia Pacific Evolocumab Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Evolocumab Market Facts & Figures by Country
3.6.1 Latin America Evolocumab Sales by Country
3.6.2 Latin America Evolocumab Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Evolocumab Market Facts & Figures by Country
3.7.1 Middle East and Africa Evolocumab Sales by Country
3.7.2 Middle East and Africa Evolocumab Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Evolocumab Historic Market Analysis by Type
4.1 Global Evolocumab Sales Market Share by Type (2017-2022)
4.2 Global Evolocumab Revenue Market Share by Type (2017-2022)
4.3 Global Evolocumab Price by Type (2017-2022)
5 Global Evolocumab Historic Market Analysis by Application
5.1 Global Evolocumab Sales Market Share by Application (2017-2022)
5.2 Global Evolocumab Revenue Market Share by Application (2017-2022)
5.3 Global Evolocumab Price by Application (2017-2022)
6 Key Companies Profiled
6.1 BOCSCI
6.1.1 BOCSCI Corporation Information
6.1.2 BOCSCI Description and Business Overview
6.1.3 BOCSCI Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.1.4 BOCSCI Evolocumab Product Portfolio
6.1.5 BOCSCI Recent Developments/Updates
6.2 Carbosynth
6.2.1 Carbosynth Corporation Information
6.2.2 Carbosynth Description and Business Overview
6.2.3 Carbosynth Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Carbosynth Evolocumab Product Portfolio
6.2.5 Carbosynth Recent Developments/Updates
6.3 TargetMol Chemicals
6.3.1 TargetMol Chemicals Corporation Information
6.3.2 TargetMol Chemicals Description and Business Overview
6.3.3 TargetMol Chemicals Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.3.4 TargetMol Chemicals Evolocumab Product Portfolio
6.3.5 TargetMol Chemicals Recent Developments/Updates
6.4 Chemren Bio-Engineering
6.4.1 Chemren Bio-Engineering Corporation Information
6.4.2 Chemren Bio-Engineering Description and Business Overview
6.4.3 Chemren Bio-Engineering Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Chemren Bio-Engineering Evolocumab Product Portfolio
6.4.5 Chemren Bio-Engineering Recent Developments/Updates
6.5 DC Chemicals
6.5.1 DC Chemicals Corporation Information
6.5.2 DC Chemicals Description and Business Overview
6.5.3 DC Chemicals Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.5.4 DC Chemicals Evolocumab Product Portfolio
6.5.5 DC Chemicals Recent Developments/Updates
6.6 Hefei Enli Medical Technology
6.6.1 Hefei Enli Medical Technology Corporation Information
6.6.2 Hefei Enli Medical Technology Description and Business Overview
6.6.3 Hefei Enli Medical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hefei Enli Medical Technology Evolocumab Product Portfolio
6.6.5 Hefei Enli Medical Technology Recent Developments/Updates
6.7 Hefei Hirisun Pharmatech
6.6.1 Hefei Hirisun Pharmatech Corporation Information
6.6.2 Hefei Hirisun Pharmatech Description and Business Overview
6.6.3 Hefei Hirisun Pharmatech Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hefei Hirisun Pharmatech Evolocumab Product Portfolio
6.7.5 Hefei Hirisun Pharmatech Recent Developments/Updates
6.8 Hubei Kele Fine Chemical
6.8.1 Hubei Kele Fine Chemical Corporation Information
6.8.2 Hubei Kele Fine Chemical Description and Business Overview
6.8.3 Hubei Kele Fine Chemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Hubei Kele Fine Chemical Evolocumab Product Portfolio
6.8.5 Hubei Kele Fine Chemical Recent Developments/Updates
6.9 Hubei Xingcheng Biotechnology
6.9.1 Hubei Xingcheng Biotechnology Corporation Information
6.9.2 Hubei Xingcheng Biotechnology Description and Business Overview
6.9.3 Hubei Xingcheng Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Hubei Xingcheng Biotechnology Evolocumab Product Portfolio
6.9.5 Hubei Xingcheng Biotechnology Recent Developments/Updates
6.10 Hubei Zhongshan Medical Technology
6.10.1 Hubei Zhongshan Medical Technology Corporation Information
6.10.2 Hubei Zhongshan Medical Technology Description and Business Overview
6.10.3 Hubei Zhongshan Medical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Hubei Zhongshan Medical Technology Evolocumab Product Portfolio
6.10.5 Hubei Zhongshan Medical Technology Recent Developments/Updates
6.11 Nantong Feiyu Biological Technology
6.11.1 Nantong Feiyu Biological Technology Corporation Information
6.11.2 Nantong Feiyu Biological Technology Evolocumab Description and Business Overview
6.11.3 Nantong Feiyu Biological Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Nantong Feiyu Biological Technology Evolocumab Product Portfolio
6.11.5 Nantong Feiyu Biological Technology Recent Developments/Updates
6.12 Nantong Hi-Future Biotechnology
6.12.1 Nantong Hi-Future Biotechnology Corporation Information
6.12.2 Nantong Hi-Future Biotechnology Evolocumab Description and Business Overview
6.12.3 Nantong Hi-Future Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Nantong Hi-Future Biotechnology Evolocumab Product Portfolio
6.12.5 Nantong Hi-Future Biotechnology Recent Developments/Updates
6.13 Shanghai Biochempartner
6.13.1 Shanghai Biochempartner Corporation Information
6.13.2 Shanghai Biochempartner Evolocumab Description and Business Overview
6.13.3 Shanghai Biochempartner Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Shanghai Biochempartner Evolocumab Product Portfolio
6.13.5 Shanghai Biochempartner Recent Developments/Updates
6.14 Shanghai Loulan Biotechnology
6.14.1 Shanghai Loulan Biotechnology Corporation Information
6.14.2 Shanghai Loulan Biotechnology Evolocumab Description and Business Overview
6.14.3 Shanghai Loulan Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Shanghai Loulan Biotechnology Evolocumab Product Portfolio
6.14.5 Shanghai Loulan Biotechnology Recent Developments/Updates
6.15 Shanghai Macklin Biochemical
6.15.1 Shanghai Macklin Biochemical Corporation Information
6.15.2 Shanghai Macklin Biochemical Evolocumab Description and Business Overview
6.15.3 Shanghai Macklin Biochemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Shanghai Macklin Biochemical Evolocumab Product Portfolio
6.15.5 Shanghai Macklin Biochemical Recent Developments/Updates
6.16 Shanghai Minkai Biotechnology
6.16.1 Shanghai Minkai Biotechnology Corporation Information
6.16.2 Shanghai Minkai Biotechnology Evolocumab Description and Business Overview
6.16.3 Shanghai Minkai Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Shanghai Minkai Biotechnology Evolocumab Product Portfolio
6.16.5 Shanghai Minkai Biotechnology Recent Developments/Updates
6.17 Shanghai Ruihui Chemical Technology
6.17.1 Shanghai Ruihui Chemical Technology Corporation Information
6.17.2 Shanghai Ruihui Chemical Technology Evolocumab Description and Business Overview
6.17.3 Shanghai Ruihui Chemical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Shanghai Ruihui Chemical Technology Evolocumab Product Portfolio
6.17.5 Shanghai Ruihui Chemical Technology Recent Developments/Updates
6.18 Shanghai Yifei Biotechnology
6.18.1 Shanghai Yifei Biotechnology Corporation Information
6.18.2 Shanghai Yifei Biotechnology Evolocumab Description and Business Overview
6.18.3 Shanghai Yifei Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Shanghai Yifei Biotechnology Evolocumab Product Portfolio
6.18.5 Shanghai Yifei Biotechnology Recent Developments/Updates
6.19 Sichuan Weiqi Biotechnology
6.19.1 Sichuan Weiqi Biotechnology Corporation Information
6.19.2 Sichuan Weiqi Biotechnology Evolocumab Description and Business Overview
6.19.3 Sichuan Weiqi Biotechnology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Sichuan Weiqi Biotechnology Evolocumab Product Portfolio
6.19.5 Sichuan Weiqi Biotechnology Recent Developments/Updates
6.20 Taizhou KEDE Chemical
6.20.1 Taizhou KEDE Chemical Corporation Information
6.20.2 Taizhou KEDE Chemical Evolocumab Description and Business Overview
6.20.3 Taizhou KEDE Chemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Taizhou KEDE Chemical Evolocumab Product Portfolio
6.20.5 Taizhou KEDE Chemical Recent Developments/Updates
6.21 Taizhou Kerui Bio-Technology
6.21.1 Taizhou Kerui Bio-Technology Corporation Information
6.21.2 Taizhou Kerui Bio-Technology Evolocumab Description and Business Overview
6.21.3 Taizhou Kerui Bio-Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Taizhou Kerui Bio-Technology Evolocumab Product Portfolio
6.21.5 Taizhou Kerui Bio-Technology Recent Developments/Updates
6.22 WeiShi Reagent
6.22.1 WeiShi Reagent Corporation Information
6.22.2 WeiShi Reagent Evolocumab Description and Business Overview
6.22.3 WeiShi Reagent Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.22.4 WeiShi Reagent Evolocumab Product Portfolio
6.22.5 WeiShi Reagent Recent Developments/Updates
6.23 Wuhan Fortuna Chemical
6.23.1 Wuhan Fortuna Chemical Corporation Information
6.23.2 Wuhan Fortuna Chemical Evolocumab Description and Business Overview
6.23.3 Wuhan Fortuna Chemical Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Wuhan Fortuna Chemical Evolocumab Product Portfolio
6.23.5 Wuhan Fortuna Chemical Recent Developments/Updates
6.24 Wuhan Sunrise Technology Development
6.24.1 Wuhan Sunrise Technology Development Corporation Information
6.24.2 Wuhan Sunrise Technology Development Evolocumab Description and Business Overview
6.24.3 Wuhan Sunrise Technology Development Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Wuhan Sunrise Technology Development Evolocumab Product Portfolio
6.24.5 Wuhan Sunrise Technology Development Recent Developments/Updates
6.25 Wuhan Weisman Bioengineering
6.25.1 Wuhan Weisman Bioengineering Corporation Information
6.25.2 Wuhan Weisman Bioengineering Evolocumab Description and Business Overview
6.25.3 Wuhan Weisman Bioengineering Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Wuhan Weisman Bioengineering Evolocumab Product Portfolio
6.25.5 Wuhan Weisman Bioengineering Recent Developments/Updates
6.26 Wuhan Yingnuo Pharmaceutical Technology
6.26.1 Wuhan Yingnuo Pharmaceutical Technology Corporation Information
6.26.2 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Description and Business Overview
6.26.3 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Wuhan Yingnuo Pharmaceutical Technology Evolocumab Product Portfolio
6.26.5 Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
7 Evolocumab Manufacturing Cost Analysis
7.1 Evolocumab Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Evolocumab
7.4 Evolocumab Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Evolocumab Distributors List
8.3 Evolocumab Customers
9 Evolocumab Market Dynamics
9.1 Evolocumab Industry Trends
9.2 Evolocumab Market Drivers
9.3 Evolocumab Market Challenges
9.4 Evolocumab Market Restraints
10 Global Market Forecast
10.1 Evolocumab Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Evolocumab by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Evolocumab by Type (2023-2028)
10.2 Evolocumab Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Evolocumab by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Evolocumab by Application (2023-2028)
10.3 Evolocumab Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Evolocumab by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Evolocumab by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Global Evolocumab Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
Table 2. Global Evolocumab Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
Table 3. Global Evolocumab Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Evolocumab Market Competitive Situation by Manufacturers in 2021
Table 5. Global Evolocumab Sales (Kg) of Key Manufacturers (2017-2022)
Table 6. Global Evolocumab Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Evolocumab Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Evolocumab Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Evolocumab Average Price (US$/Kg) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Evolocumab Manufacturing Sites and Area Served
Table 11. Manufacturers Evolocumab Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Evolocumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Evolocumab as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Evolocumab Sales by Region (2017-2022) & (Kg)
Table 16. Global Evolocumab Sales Market Share by Region (2017-2022)
Table 17. Global Evolocumab Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Evolocumab Revenue Market Share by Region (2017-2022)
Table 19. North America Evolocumab Sales by Country (2017-2022) & (Kg)
Table 20. North America Evolocumab Sales Market Share by Country (2017-2022)
Table 21. North America Evolocumab Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Evolocumab Revenue Market Share by Country (2017-2022)
Table 23. Europe Evolocumab Sales by Country (2017-2022) & (Kg)
Table 24. Europe Evolocumab Sales Market Share by Country (2017-2022)
Table 25. Europe Evolocumab Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Evolocumab Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Evolocumab Sales by Region (2017-2022) & (Kg)
Table 28. Asia Pacific Evolocumab Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Evolocumab Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Evolocumab Revenue Market Share by Region (2017-2022)
Table 31. Latin America Evolocumab Sales by Country (2017-2022) & (Kg)
Table 32. Latin America Evolocumab Sales Market Share by Country (2017-2022)
Table 33. Latin America Evolocumab Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Evolocumab Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Evolocumab Sales by Country (2017-2022) & (Kg)
Table 36. Middle East and Africa Evolocumab Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Evolocumab Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Evolocumab Revenue Market Share by Country (2017-2022)
Table 39. Global Evolocumab Sales by Type (2017-2022) & (Kg)
Table 40. Global Evolocumab Sales Market Share by Type (2017-2022)
Table 41. Global Evolocumab Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Evolocumab Revenue Share by Type (2017-2022)
Table 43. Global Evolocumab Price by Type (2017-2022) & (US$/Kg)
Table 44. Global Evolocumab Sales (Kg) by Application (2017-2022)
Table 45. Global Evolocumab Sales Market Share by Application (2017-2022)
Table 46. Global Evolocumab Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Evolocumab Revenue Share by Application (2017-2022)
Table 48. Global Evolocumab Price by Application (2017-2022) & (US$/Kg)
Table 49. BOCSCI Corporation Information
Table 50. BOCSCI Description and Business Overview
Table 51. BOCSCI Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 52. BOCSCI Evolocumab Product
Table 53. BOCSCI Recent Developments/Updates
Table 54. Carbosynth Corporation Information
Table 55. Carbosynth Description and Business Overview
Table 56. Carbosynth Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 57. Carbosynth Evolocumab Product
Table 58. Carbosynth Recent Developments/Updates
Table 59. TargetMol Chemicals Corporation Information
Table 60. TargetMol Chemicals Description and Business Overview
Table 61. TargetMol Chemicals Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 62. TargetMol Chemicals Evolocumab Product
Table 63. TargetMol Chemicals Recent Developments/Updates
Table 64. Chemren Bio-Engineering Corporation Information
Table 65. Chemren Bio-Engineering Description and Business Overview
Table 66. Chemren Bio-Engineering Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 67. Chemren Bio-Engineering Evolocumab Product
Table 68. Chemren Bio-Engineering Recent Developments/Updates
Table 69. DC Chemicals Corporation Information
Table 70. DC Chemicals Description and Business Overview
Table 71. DC Chemicals Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 72. DC Chemicals Evolocumab Product
Table 73. DC Chemicals Recent Developments/Updates
Table 74. Hefei Enli Medical Technology Corporation Information
Table 75. Hefei Enli Medical Technology Description and Business Overview
Table 76. Hefei Enli Medical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 77. Hefei Enli Medical Technology Evolocumab Product
Table 78. Hefei Enli Medical Technology Recent Developments/Updates
Table 79. Hefei Hirisun Pharmatech Corporation Information
Table 80. Hefei Hirisun Pharmatech Description and Business Overview
Table 81. Hefei Hirisun Pharmatech Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 82. Hefei Hirisun Pharmatech Evolocumab Product
Table 83. Hefei Hirisun Pharmatech Recent Developments/Updates
Table 84. Hubei Kele Fine Chemical Corporation Information
Table 85. Hubei Kele Fine Chemical Description and Business Overview
Table 86. Hubei Kele Fine Chemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 87. Hubei Kele Fine Chemical Evolocumab Product
Table 88. Hubei Kele Fine Chemical Recent Developments/Updates
Table 89. Hubei Xingcheng Biotechnology Corporation Information
Table 90. Hubei Xingcheng Biotechnology Description and Business Overview
Table 91. Hubei Xingcheng Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 92. Hubei Xingcheng Biotechnology Evolocumab Product
Table 93. Hubei Xingcheng Biotechnology Recent Developments/Updates
Table 94. Hubei Zhongshan Medical Technology Corporation Information
Table 95. Hubei Zhongshan Medical Technology Description and Business Overview
Table 96. Hubei Zhongshan Medical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 97. Hubei Zhongshan Medical Technology Evolocumab Product
Table 98. Hubei Zhongshan Medical Technology Recent Developments/Updates
Table 99. Nantong Feiyu Biological Technology Corporation Information
Table 100. Nantong Feiyu Biological Technology Description and Business Overview
Table 101. Nantong Feiyu Biological Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 102. Nantong Feiyu Biological Technology Evolocumab Product
Table 103. Nantong Feiyu Biological Technology Recent Developments/Updates
Table 104. Nantong Hi-Future Biotechnology Corporation Information
Table 105. Nantong Hi-Future Biotechnology Description and Business Overview
Table 106. Nantong Hi-Future Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 107. Nantong Hi-Future Biotechnology Evolocumab Product
Table 108. Nantong Hi-Future Biotechnology Recent Developments/Updates
Table 109. Shanghai Biochempartner Corporation Information
Table 110. Shanghai Biochempartner Description and Business Overview
Table 111. Shanghai Biochempartner Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 112. Shanghai Biochempartner Evolocumab Product
Table 113. Shanghai Biochempartner Recent Developments/Updates
Table 114. Shanghai Loulan Biotechnology Corporation Information
Table 115. Shanghai Loulan Biotechnology Description and Business Overview
Table 116. Shanghai Loulan Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 117. Shanghai Loulan Biotechnology Evolocumab Product
Table 118. Shanghai Loulan Biotechnology Recent Developments/Updates
Table 119. Shanghai Macklin Biochemical Corporation Information
Table 120. Shanghai Macklin Biochemical Description and Business Overview
Table 121. Shanghai Macklin Biochemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 122. Shanghai Macklin Biochemical Evolocumab Product
Table 123. Shanghai Macklin Biochemical Recent Developments/Updates
Table 124. Shanghai Minkai Biotechnology Corporation Information
Table 125. Shanghai Minkai Biotechnology Description and Business Overview
Table 126. Shanghai Minkai Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 127. Shanghai Minkai Biotechnology Evolocumab Product
Table 128. Shanghai Minkai Biotechnology Recent Developments/Updates
Table 129. Shanghai Ruihui Chemical Technology Corporation Information
Table 130. Shanghai Ruihui Chemical Technology Description and Business Overview
Table 131. Shanghai Ruihui Chemical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 132. Shanghai Ruihui Chemical Technology Evolocumab Product
Table 133. Shanghai Ruihui Chemical Technology Recent Developments/Updates
Table 134. Shanghai Yifei Biotechnology Corporation Information
Table 135. Shanghai Yifei Biotechnology Description and Business Overview
Table 136. Shanghai Yifei Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 137. Shanghai Yifei Biotechnology Evolocumab Product
Table 138. Shanghai Yifei Biotechnology Recent Developments/Updates
Table 139. Sichuan Weiqi Biotechnology Corporation Information
Table 140. Sichuan Weiqi Biotechnology Description and Business Overview
Table 141. Sichuan Weiqi Biotechnology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 142. Sichuan Weiqi Biotechnology Evolocumab Product
Table 143. Sichuan Weiqi Biotechnology Recent Developments/Updates
Table 144. Taizhou KEDE Chemical Corporation Information
Table 145. Taizhou KEDE Chemical Description and Business Overview
Table 146. Taizhou KEDE Chemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 147. Taizhou KEDE Chemical Evolocumab Product
Table 148. Taizhou KEDE Chemical Recent Developments/Updates
Table 149. Taizhou Kerui Bio-Technology Corporation Information
Table 150. Taizhou Kerui Bio-Technology Description and Business Overview
Table 151. Taizhou Kerui Bio-Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 152. Taizhou Kerui Bio-Technology Evolocumab Product
Table 153. Taizhou Kerui Bio-Technology Recent Developments/Updates
Table 154. WeiShi Reagent Corporation Information
Table 155. WeiShi Reagent Description and Business Overview
Table 156. WeiShi Reagent Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 157. WeiShi Reagent Evolocumab Product
Table 158. WeiShi Reagent Recent Developments/Updates
Table 159. Wuhan Fortuna Chemical Corporation Information
Table 160. Wuhan Fortuna Chemical Description and Business Overview
Table 161. Wuhan Fortuna Chemical Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 162. Wuhan Fortuna Chemical Evolocumab Product
Table 163. Wuhan Fortuna Chemical Recent Developments/Updates
Table 164. Wuhan Sunrise Technology Development Corporation Information
Table 165. Wuhan Sunrise Technology Development Description and Business Overview
Table 166. Wuhan Sunrise Technology Development Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 167. Wuhan Sunrise Technology Development Evolocumab Product
Table 168. Wuhan Sunrise Technology Development Recent Developments/Updates
Table 169. Wuhan Weisman Bioengineering Corporation Information
Table 170. Wuhan Weisman Bioengineering Description and Business Overview
Table 171. Wuhan Weisman Bioengineering Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 172. Wuhan Weisman Bioengineering Evolocumab Product
Table 173. Wuhan Weisman Bioengineering Recent Developments/Updates
Table 174. Wuhan Yingnuo Pharmaceutical Technology Corporation Information
Table 175. Wuhan Yingnuo Pharmaceutical Technology Description and Business Overview
Table 176. Wuhan Yingnuo Pharmaceutical Technology Evolocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 177. Wuhan Yingnuo Pharmaceutical Technology Evolocumab Product
Table 178. Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
Table 179. Production Base and Market Concentration Rate of Raw Material
Table 180. Key Suppliers of Raw Materials
Table 181. Evolocumab Distributors List
Table 182. Evolocumab Customers List
Table 183. Evolocumab Market Trends
Table 184. Evolocumab Market Drivers
Table 185. Evolocumab Market Challenges
Table 186. Evolocumab Market Restraints
Table 187. Global Evolocumab Sales Forecast by Type (2023-2028) & (Kg)
Table 188. Global Evolocumab Sales Market Share Forecast by Type (2023-2028)
Table 189. Global Evolocumab Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 190. Global Evolocumab Revenue Market Share Forecast by Type (2023-2028)
Table 191. Global Evolocumab Sales Forecast by Application (2023-2028) & (Kg)
Table 192. Global Evolocumab Sales Market Share Forecast by Application (2023-2028)
Table 193. Global Evolocumab Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 194. Global Evolocumab Revenue Market Share Forecast by Application (2023-2028)
Table 195. Global Evolocumab Sales Forecast by Region (2023-2028) & (Kg)
Table 196. Global Evolocumab Sales Market Share Forecast by Region (2023-2028)
Table 197. Global Evolocumab Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 198. Global Evolocumab Revenue Market Share Forecast by Region (2023-2028)
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Evolocumab
Figure 2. Global Evolocumab Market Share by Type in 2021 & 2028
Figure 3. Patent Product Picture
Figure 4. Generic Product Picture
Figure 5. Global Evolocumab Market Share by Application in 2021 & 2028
Figure 6. Chemical
Figure 7. Pharmaceutical
Figure 8. Global Evolocumab Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Evolocumab Market Size (2017-2028) & (US$ Million)
Figure 10. Global Evolocumab Sales (2017-2028) & (Kg)
Figure 11. Evolocumab Sales Share by Manufacturers in 2021
Figure 12. Global Evolocumab Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Evolocumab Players: Market Share by Revenue in 2021
Figure 14. Evolocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Evolocumab Sales Market Share by Region (2017-2022)
Figure 16. Global Evolocumab Sales Market Share by Region in 2021
Figure 17. Global Evolocumab Revenue Market Share by Region (2017-2022)
Figure 18. Global Evolocumab Revenue Market Share by Region in 2021
Figure 19. United States Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Turkey Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Saudi Arabia Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. UAE Evolocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Sales Market Share of Evolocumab by Type (2017-2022)
Figure 42. Manufacturing Cost Structure of Evolocumab
Figure 43. Manufacturing Process Analysis of Evolocumab
Figure 44. Evolocumab Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Evolocumab Market

Leave This Empty: